(3D) Ultrasound Imaging Liver and Kidney
Liver Cancer | Kidney CancerThis study is to assess the addition of 3D ultrasound guidance during standard care ablation or biopsies of liver or kidney tumours. 3D ultrasound only differs from conventional 2D ultrasound in that the ultrasound transducer is mounted on a special assembly that moves the transducer in precise, stepped movements while a succession of 2D images are collected by the computer. Special software written specifically for 3D ultrasound precisely aligns these 2D images into a 3-demensional volume , allowing area in question to be viewed in many different planes. 3D ultrasound is a safe, fast, non-invasive imaging procedure. Ultrasound images will be checked against the pre- and post- procedure CT images to make sure the tumours were completely removed or properly targeted during biopsy.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* • Patients who are scheduled for standard care liver or kidney ablation or biopsy
Exclusion Criteria:
* None
Study Location
Victoria Hospital
Victoria HospitalLondon, Ontario
Canada
Contact Study Team
Derek Cool, MD/PhD
5196858500- Study Sponsored By
- Western University, Canada
- Participants Required
- More Information
- Study ID:
NCT03844399